13F-HR filed by Artia Global Partners LP
Artia Global Partners LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 48 holding rows worth $541,855,576.
- Accession
- 0001937964-26-000008
- Filer
- CIK 1937964
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 48 entries on the cover page, a total value of $541,855,576 stated on the cover page (in dollars after the unit check, H1), rows summing to $541,855,576 with VALUE read as dollars as filed, 13F file number 028-23071. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 516,447 | $68,821,727 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 589,052 | $62,804,724 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 2,210,852 | $41,232,390 | dollars as filed | |
| BRIGHTSPRING HEALTH SVCS | 10950A106 | COM | 517,315 | $36,077,548 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 185,390 | $34,719,839 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 29,739 | $27,590,952 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 448,964 | $23,523,469 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 339,033 | $19,260,465 | dollars as filed | |
| ASTRAZENECA PLC ORD | G0593M107 | ADR | 98,376 | $18,654,057 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 503,936 | $17,078,391 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 162,990 | $15,888,265 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 100,000 | $15,825,000 | dollars as filed | put |
| QUEST DIAGNOSTICS INC COM | 74834L100 | Stock | 65,122 | $13,802,608 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 144,376 | $11,447,573 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 767,098 | $10,969,501 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 278,546 | $7,838,284 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 180,731 | $7,050,316 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 59,316 | $6,205,640 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 70,700 | $6,022,933 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 46,700 | $6,000,950 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 138,508 | $5,771,628 | dollars as filed | |
| Johnson & Johnson | 478160104 | COM | 22,600 | $5,739,722 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 38,100 | $5,716,143 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 464,444 | $5,382,906 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 96,285 | $5,295,675 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 119,741 | $5,267,407 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 17,740 | $4,731,613 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 129,800 | $4,593,622 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 1,992,367 | $4,164,047 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 98,800 | $4,014,244 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 18,437 | $3,983,498 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 65,000 | $3,923,400 | dollars as filed | |
| BELITE BIO INC | 07782B104 | CMN | 24,989 | $3,847,931 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 137,800 | $3,717,844 | dollars as filed | |
| PROKIDNEY CORP | 74291D104 | CMN | 1,806,939 | $3,686,156 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 72,100 | $3,659,075 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 33,400 | $3,178,678 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 22,951 | $2,813,334 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 5,000 | $2,709,150 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 38,407 | $2,696,171 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 29,200 | $1,867,340 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 383,200 | $839,208 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 2,500 | $836,975 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 17,019 | $663,060 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 42,080 | $612,264 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 4,900 | $605,150 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 205,324 | $369,583 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 4,000 | $355,120 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001937964-26-000008 | this filing | 2026-08-14 | acceptance time not in the bulk data set |